Fungal cell

A **fungal cell** is a eukaryotic organismal unit that possesses a complex internal structure including a nucleus and various organelles such as mitochondria and endoplasmic reticulum. The most distinctive features are its rigid **cell wall**, primarily composed of chitin and glucans—unlike plant cells which use cellulose—and its plasma membrane containing ergosterol instead of cholesterol. The fungal cell wall provides structural support and protection from environmental stressors. Fungi can exist as unicellular yeasts or multicellular forms with hyphae; these structures enable them to decompose organic matter and recycle nutrients in ecosystems. Fungal cells are not themselves considered therapeutic targets; rather, specific molecular components unique to fungi—such as enzymes involved in chitin or glucan biosynthesis or those responsible for ergosterol production—are targeted by antifungal drugs. Thus, "fungal cells" is too broad for use as a canonical drug target name. Instead, more precise targets include "β-(1,3)-D-glucan synthase," "ergosterol biosynthetic enzymes," etc. **Note:** There is something incorrect about using “Fungal cells” as a therapeutic target because it refers to an entire class/type of organism rather than a specific molecular entity suitable for drug targeting. For structured data purposes you should specify individual molecular targets within fungal cells rather than the whole-cell level. **Key distinguishing features:** • Rigid chitin/glucan-rich wall • Ergosterol-containing plasma membrane • Eukaryotic organelle composition **Common antifungal mechanisms:** • Targeting ergosterol biosynthesis or function [azoles/amphotericin B] • Blocking β-(1,3)-D-glucan formation [echinocandins] If you need information on specific *molecular* targets within fungal cells—for example “β-(1,3)-D-glucan synthase” or “Erg11/lanosterol 14α-demethylase”—please specify so structured data can be provided at that level.

Other names

Fungi cellFungus cellEukaryotic fungal cell

Inhibition of ergosterol synthesis in the plasma membrane (azoles); Disruption of membrane integrity by binding to ergosterol (amphotericin B); Inhibition of β-(1,3)-D-glucan synthesis in the cell wall (echinocandins); Inhibition of DNA/RNA synthesis after conversion to 5-fluorouracil inside fungal cells (flucytosine)